Showing results (111-120 of 234) with videos related to

Sort By:
Pageof 24
Experimental Hematology & Oncology|February 19, 2021
Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphomaPatrick B Johnston, Amanda F Cashen, Petros G Nikolinakos, et al.
International Journal of Radiation Oncology, Biology, Physics|March 11, 2015
Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphomaRanda Tao, Pamela K Allen, Alma Rodriguez, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 15, 2016
P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphomaXuan J Wang, L Jeffrey Medeiros, Carlos E Bueso-Ramos, et al.
Haematologica|November 27, 2025
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphomaAdam J Olszewski, Thomas A Ollila, Dai Chihara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2014
High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective studyDai Chihara, Koji Izutsu, Eisei Kondo, et al.
British Journal of Haematology|June 16, 2016
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trialDai Chihara, Hagop Kantarjian, Susan O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphomaMichael Wang, Yasuhiro Oki, Barbara Pro, et al.
Haematologica|March 19, 2026
Salvage high-dose chemotherapy and autologous stem cell transplant consolidation following relapse after CAR-T cell for large B-cell lymphomaJeremy Ramdial, Erica Agbadiba, Misha Hawkins, et al.
British Journal of Haematology|January 7, 2014
The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphomaYasuhiro Oki, Hubert Chuang, Beth Chasen, et al.
Blood|January 10, 2015
Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expressionEric D Jacobsen, Jeff P Sharman, Yasuhiro Oki, et al.
Pageof 24